DA
PFE icon

Detalus Advisors’s Pfizer PFE Stock Holding History

Detalus Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
9,309
+1,346
+17% +$35.2K 0.04% 178
2026
Q1 		$224K Buy
+7,963
New +$212K 0.05% 167
2025
Q4 		– Sell
-7,910
Closed -$202K – 178
2025
Q3 		$202K Sell
7,910
-972
-11% -$24K 0.05% 170
2025
Q2 		$215K Buy
+8,882
New +$207K 0.06% 160
2025
Q1 		– Sell
-7,706
Closed -$204K – 166
2024
Q4 		$204K Sell
7,706
-1,976
-20% -$53.6K 0.07% 142
2024
Q3 		$280K Sell
9,682
-15,362
-61% -$448K 0.09% 126
2024
Q2 		$701K Sell
25,044
-196
-0.8% -$5.4K 0.24% 57
2024
Q1 		$700K Buy
25,240
+242
+1% +$6.71K 0.25% 58
2023
Q4 		$720K Sell
24,998
-5,539
-18% -$167K 0.29% 54
2023
Q3 		$1.01M Sell
30,537
-139
-0.5% -$4.92K 0.47% 39
2023
Q2 		$1.13M Sell
30,676
-1,711
-5% -$66.6K 0.5% 39
2023
Q1 		$1.32M Buy
32,387
+87
+0.3% +$3.76K 0.63% 32
2022
Q4 		$1.66M Sell
32,300
-670
-2% -$32.1K 0.81% 27
2022
Q3 		$1.44M Buy
32,970
+42
+0.1% +$2.04K 0.86% 22
2022
Q2 		$1.73M Sell
32,928
-266
-0.8% -$13.6K 1.01% 17
2022
Q1 		$1.72M Sell
33,194
-2,734
-8% -$142K 0.9% 19
2021
Q4 		$2.12M Sell
35,928
-532
-1% -$26.4K 1.02% 18
2021
Q3 		$1.57M Buy
36,460
+3,310
+10% +$147K 0.8% 21
2021
Q2 		$1.3M Buy
33,150
+5,817
+21% +$226K 0.69% 24
2021
Q1 		$990K Buy
27,333
+277
+1% +$9.84K 0.58% 29
2020
Q4 		$996K Sell
27,056
-2,215
-8% -$81.2K 0.63% 23
2020
Q3 		$1.02M Buy
29,271
+373
+1% +$13.1K 0.74% 20
2020
Q2 		$897K Buy
28,898
+1,910
+7% +$64.9K 0.69% 18
2020
Q1 		$836K Buy
26,988
+5,061
+23% +$172K 0.77% 18
2019
Q4 		$815K Buy
+21,927
New +$781K 0.59% 28

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Detalus Advisors's PFE Position: Q2 2026 in Review

Detalus Advisors increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $35.2K and bringing the position to 9,309 shares worth $224K. The position accounts for 0.04% of the portfolio, ranked #178.

Detalus Advisors first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.12M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Detalus Advisors held 9,309 shares of Pfizer worth $224K as of Q2 2026.
  • Detalus Advisors bought 1,346 Pfizer shares in Q2 2026, an estimated $35.2K.
  • Pfizer made up 0.04% of Detalus Advisors's portfolio in Q2 2026, its #178 holding.
  • Detalus Advisors first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • Detalus Advisors's Pfizer position peaked at $2.12M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.